Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Pipeline Insight, 2017

Publisher Name :
Date: 01-Nov-2017
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)

  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)

  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information

  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)

  • The report also covers the dormant and discontinued pipeline projects related to the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)

Reasons to Buy

  • Establish comprehensive understanding of the pipeline activity across this Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) to formulate effective R&D strategies

  • Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine

  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) therapeutics

  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Pipeline Insight, 2017

Table of Contents

1. Report Introduction

2. Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Overview

3. Pipeline Therapeutics
An Overview of Pipeline Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Total Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)
Table 2: Products in Clinical Stage
Table 3: Products in Pre-Clinical and Discovery Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures

Figure 1:Total Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)
Figure 2: Products in Clinical Stage
Figure 3: Products in Pre-Clinical and Discovery Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 199
    Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2018, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline landscape. Coronary artery disease (CAD) is the most common type of heart disease. CAD happ......
  • Left Ventricular Dysfunction - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 47
    Left Ventricular Dysfunction - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2018, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular h......
  • Dilated Cardiomyopathy - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 67
    Dilated Cardiomyopathy - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2018, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged an......
  • Global Coronary Artery Disease Therapeutics Sales Market Report 2018
    Published: 17-Jan-2018        Price: US 4000 Onwards        Pages: 101
    In this report, the global Coronary Artery Disease Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Coronary Artery Disease Therapeutics for these regions, from 2013 to 2025 (forecast), covering - United States -......
  • Heart Transplant Rejection - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection - Pipeline Review, H2 2017, provides an overview of the Heart Transplant Rejection (Immunology) pipeline landscape. Heart transplantation is the therapy used in various heart diseases. Heart transplant replaces an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Followi......
  • 2017-2022 Transcatheter Mitral Valve Replacement Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 13-Dec-2017        Price: US 3300 Onwards        Pages: 97
    This report studies the global Transcatheter Mitral Valve Replacement market, analyzes and researches the Transcatheter Mitral Valve Replacement development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Abbott Laboratories - Edwards Lifesciences - Micro Interventional Devices - Neovasc - MitrAssist - NaviGate Cardiac Structures - Valtech ......
  • Myocardial Fibrosis - Pipeline Review, H2 2017
    Published: 13-Dec-2017        Price: US 2000 Onwards        Pages: 85
    Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Pipeline Review, H2 2017, provides an overview of the Myocardial Fibrosis (Cardiovascular) pipeline landscape. Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal swelling, nausea and fatigue. Report Highlights......
  • Myocardial Ischemia - Pipeline Review, H2 2017
    Published: 30-Nov-2017        Price: US 2000 Onwards        Pages: 66
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia - Pipeline Review, H2 2017, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, short......
  • Myocardial Infarction -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Myocardial Infarction - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Myocardial Infarction in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Myocardial Infarction prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need ass......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs